Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study
炎症性风湿病中生物制剂和靶向合成DMARDs成本效益应用的考量因素:一项伞状综述和国际德尔菲研究的结果
期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2022-002898
van der Togt, Céleste J T; Van den Bemt, Bart; Aletaha, Daniel; Alten, Rieke; Chatzidionysiou, Katerina; Galloway, James; Isaac, John; Mulleman, Denis; Verschueren, P; Vulto, Arnold G; Welsing, Paco M J; Verhoef, Lise; den Broeder, Alfons A